PHARMACEUTICAL COMPOSITION COMPRISING THE PDE4 ENZYME INHIBITOR REVAMILAST AND A DISEASE MODIFYING AGENT, PREFERABLY METHOTREXATE

The present patent application relates to a pharmaceutical composition comprising a PDE4 enzyme inhibitor and a disease modifying agent; a process for preparing such composition; and its use in treating an autoimmune disease in a subject. La présente demande de brevet concerne une composition pharma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANUPINDI, RAGHURAM, VAIYAPURI, THAMIL SELVAN, KHAIRATKAR-JOSHI, NEELIMA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present patent application relates to a pharmaceutical composition comprising a PDE4 enzyme inhibitor and a disease modifying agent; a process for preparing such composition; and its use in treating an autoimmune disease in a subject. La présente demande de brevet concerne une composition pharmaceutique comprenant un inhibiteur d'enzyme PDE4 et un agent de modification pathologique ; un procédé pour la préparer ; et son utilisation pour traiter une maladie auto-immune chez un sujet.